老年人跌倒:与枪支相比,这是一个巨大的经济负担
Bardiya Zangbar1, Aryan Rafieezadeh1, Gabriel Rodriguez1
1Surgery, Westchester Medical Center, Valhalla, New York, USA.
Trauma surgery & acute care open
|October 17, 2024
概括
致命的跌倒导致的医疗费用高于枪支伤害,特别是在老年人身上. 2019年以后,跌倒的整体经济负担超过了枪支伤害,这表明社会影响越来越大.
科学领域:
- 公共卫生 公共卫生
- 老年学是一门学科.
- 卫生经济学 卫生经济学
背景情况:
- 致命的枪支伤害是一个重要的公共卫生问题.
- 致命的跌倒是一个越来越大的挑战,特别是随着人口老龄化.
- 这项研究比较了与致命跌倒和枪支伤害相关的成本.
研究的目的:
- 评估和比较医疗和致命的枪支伤害和致命的跌倒在五年期间的综合成本.
- 分析不同年龄组这些成本的趋势.
- 了解这些伤害类型的社会经济影响.
主要方法:
- 使用了基于Web的伤害统计查询和报告系统 (WISQARS) 的数据.
- 分析了年龄在15-85岁之间的致命枪支和跌倒数据.
- 检查的医疗费用和综合费用 (医疗费用+统计生活价值).
主要成果:
- 从2015年到2020年,致命的跌倒显示了所有年龄组的医疗费用显著增加.
- 2019年以后,致命跌倒的综合成本超过了致命枪支伤害的总成本,特别是在45-85岁以上的年龄段.
- 从2015年至2020年间,致命跌倒的比例显著增加,2019年之后出现了更为急剧的增长,特别是在65岁以上的人群中.
结论:
- 老年人致命跌倒的医疗费用远高于致命的枪支伤害.
- 致命跌倒的总成本不断增加,凸显了与人口老龄化相关的日益增长的社会经济负担.
- 为了减轻老年人跌倒相关伤害的干预措施对于公共卫生和经济原因至关重要.
相关概念视频
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...